Key Takeaways
- • CME Group launched single-stock futures on 50+ leading U.S. stocks on July 27, 2026, including Alphabet, Amazon, Apple, Meta, Nvidia, and SpaceX, with both standard and micro-sized contract offerings (55 larger and 22 micro contracts).
- • The new product provides investors with capital-efficient alternatives for managing targeted single-name equity exposure and hedging, complementing CME's existing broad market index offerings.
- • CME's derivatives business is experiencing significant momentum: futures average daily volume reached 7.2 million contracts (up 12% year-over-year) with record average futures open interest of 5.4 million contracts in 2026.
- • The single-stock futures are financially settled and accessible across S&P 500, Nasdaq-100, and Russell 1000 constituents, enabling both institutional and retail market participants to gain precision exposure to mega-cap equities.
- • Tim McCourt, Global Head of Equities, FX and Alternative Products at CME Group, emphasized that the product streamlines access to liquid U.S. stocks and enables seamless transitions between broad market hedging and single-name strategies.
Summary
CME Group officially launched single-stock futures on July 27, 2026, expanding its derivatives offerings across more than 50 of the top U.S. stocks. The offering includes 55 standard-sized contracts and 22 micro-sized contracts, providing market participants with flexible instruments to manage equity price risk with greater precision and capital efficiency. The launch covers major companies including Alphabet, Amazon, Apple, Meta, Nvidia, and SpaceX, drawn from the S&P 500, Nasdaq-100, and Russell 1000 indices.
The new single-stock futures contracts are financially settled, addressing demand from both institutional and retail investors seeking alternatives to traditional equity options and stock ownership for gaining targeted exposure or hedging purposes. According to Tim McCourt, Global Head of Equities, FX and Alternative Products at CME Group, "Clients want to manage equity price risk with more precision and with the capital efficiencies of a centralized marketplace." The product is designed to simplify access to the most liquid U.S. stocks while enabling traders to transition seamlessly between broad market index hedging and single-name strategies.
CME Group's timing reflects strong underlying demand for equity derivatives. The exchange reported record performance metrics in 2026, with futures and options achieving average daily volume of 8.6 million contracts and average open interest of 11.7 million contracts. Futures specifically posted average daily volume of 7.2 million contracts, representing a 12% year-over-year increase, alongside record average futures open interest of 5.4 million contracts. This momentum underscores sustained appetite for derivatives-based risk management and speculation across institutional and retail segments.
The launch addresses a competitive gap in the U.S. derivatives market. By offering both standard and micro-sized contracts on individual mega-cap stocks, CME enables investors to customize position sizing and leverage according to their risk profiles and capital constraints. The micro contracts are particularly significant for retail and smaller institutional participants, lowering the capital barrier to accessing single-name exposure through centralized, regulated futures markets rather than relying exclusively on options or direct equity positions.
The new single-stock futures contracts are financially settled, addressing demand from both institutional and retail investors seeking alternatives to traditional equity options and stock ownership for gaining targeted exposure or hedging purposes. According to Tim McCourt, Global Head of Equities, FX and Alternative Products at CME Group, "Clients want to manage equity price risk with more precision and with the capital efficiencies of a centralized marketplace." The product is designed to simplify access to the most liquid U.S. stocks while enabling traders to transition seamlessly between broad market index hedging and single-name strategies.
CME Group's timing reflects strong underlying demand for equity derivatives. The exchange reported record performance metrics in 2026, with futures and options achieving average daily volume of 8.6 million contracts and average open interest of 11.7 million contracts. Futures specifically posted average daily volume of 7.2 million contracts, representing a 12% year-over-year increase, alongside record average futures open interest of 5.4 million contracts. This momentum underscores sustained appetite for derivatives-based risk management and speculation across institutional and retail segments.
The launch addresses a competitive gap in the U.S. derivatives market. By offering both standard and micro-sized contracts on individual mega-cap stocks, CME enables investors to customize position sizing and leverage according to their risk profiles and capital constraints. The micro contracts are particularly significant for retail and smaller institutional participants, lowering the capital barrier to accessing single-name exposure through centralized, regulated futures markets rather than relying exclusively on options or direct equity positions.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.